Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study - Sahebjam, S; Forsyth, PA; Tran, ND; Arrington, JA; Macaulay, R; Etame, AB (Neuro Oncol, 2020)